Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,295.00    -10.00 (-0.43%)
Bid:
2,295.00
Ask:
2,305.00
Spread: 10.00 (0.436%)
Market Cap: £3.11b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

17 May 2023 07:00

RNS Number : 6319Z
RIT Capital Partners PLC
17 May 2023
 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

17 May 2023

 

Net Asset Value

 

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 30 April 2023 (with debt at fair value) was 2,367p per £1 ordinary share (31 March 2023: 2,405p). This is after deduction of the first interim dividend of 19p per £1 ordinary share paid on 28 April 2023.

 

April 2023 Highlights

 

Global equity markets were broadly stable in April as Q1 economic indicators and quarterly earnings remained healthy, while overall sentiment was impacted by the prospects for further rate rises and continued concerns around banking system stability. Against this backdrop, we continued to maintain a cautious net quoted equity exposure of around 37%, at the low end of our historical range.

 

· The Quoted Equities book saw healthy performance from Japan and Healthcare, partly offset by weakness in China.

· In our Private Investments book, ~12% of our private funds have reported valuations to 31 March and ~86% are held at 31 December valuations. Our second largest direct private holding, Webull, completed an equity issuance in April at a price above carrying value.

· Our Uncorrelated Strategies showed healthy performance, helped by positive contributions from market neutral strategies and continued momentum in gold.

· The key headwind during the period was currency movements, with Sterling recording gains against major currencies including the Dollar, the Euro and the Yen.

· Our share price benefitted from a narrowing of the discount, with the shares closing the month at a discount to NAV of -15.3%. The Board continued to take advantage of the discount, buying back 1.1 million shares in April. This directly benefits shareholders through the accretive impact to NAV per share.

· The portfolio continues to hold a substantial liquidity balance. As at 30 April, total cash and short-term gilts were approximately £358 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVQQLFFXELXBBE
Date   Source Headline
23rd Dec 20207:00 amRNSTransaction in Own Shares
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
16th Dec 20207:00 amRNSTransaction in Own Shares
15th Dec 20207:00 amRNSTransaction in Own Shares
14th Dec 20207:00 amRNSNet Asset Value(s)
4th Dec 20205:36 pmRNSDirector/PDMR Shareholding
20th Nov 20204:04 pmRNSDirector/PDMR Shareholding
17th Nov 20205:27 pmRNSDirector/PDMR Shareholding
13th Nov 20207:00 amRNSNet Asset Value(s)
2nd Nov 20207:30 amRNSTransaction in Own Shares
30th Oct 20207:30 amRNSTransaction in Own Shares
15th Oct 20207:00 amRNSNet Asset Value(s)
15th Sep 20207:00 amRNSNet Asset Value(s)
17th Aug 20207:00 amRNSNet Asset Value(s)
4th Aug 20207:00 amRNSHalf-year Report
21st Jul 20207:00 amRNSNet Asset Value(s)
10th Jul 20205:25 pmRNSCommittee changes
18th Jun 20203:45 pmRNSDirector/PDMR Shareholding
15th Jun 20207:00 amRNSNet Asset Value(s)
26th May 20205:15 pmRNSResult of AGM
18th May 20207:00 amRNSNet Asset Value(s)
7th May 20206:02 pmRNSDirector/PDMR Shareholding
30th Apr 202011:12 amRNSDisclosure of Rights Attached To Ordinary Shares
21st Apr 202010:05 amRNSNotice of AGM
17th Apr 20207:00 amRNSNet Asset Value(s)
6th Apr 20205:41 pmRNSDirector/PDMR Shareholding
1st Apr 20204:06 pmRNSDirector/PDMR Shareholding
24th Mar 20205:16 pmRNSAnnual General Meeting 2020 postponement
16th Mar 20207:00 amRNSNet Asset Value(s)
11th Mar 20203:47 pmRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSAnnual Financial Report
17th Feb 20207:00 amRNSNet Asset Value(s)
5th Feb 20207:00 amRNSNet Asset Value(s)
7th Jan 20204:19 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Dec 20197:00 amRNSIssue of Equity
16th Dec 20197:00 amRNSNet Asset Value(s)
4th Dec 20195:02 pmRNSComposition of Board Committee
15th Nov 20197:00 amRNSNet Asset Value(s)
22nd Oct 20195:10 pmRNSHolding(s) in Company
14th Oct 20197:00 amRNSNet Asset Value(s)
3rd Oct 20193:17 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Sep 201912:18 pmRNSCorrection
16th Sep 20197:00 amRNSNet Asset Value(s)
14th Aug 20197:00 amRNSNet Asset Value(s)
5th Aug 20197:00 amRNSHalf-year Report
17th Jul 20197:00 amRNSNet Asset Value(s)
3rd Jul 20192:42 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
18th Jun 20195:04 pmRNSDirector/PDMR Shareholding
17th Jun 20194:20 pmRNSHolding(s) in Company
14th Jun 20197:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.